Search Results - "Rogers, Kelly C."

Clinical Efficacy and Safety of Cilostazol: A Critical Review of the Literature by Rogers, Kelly C., Oliphant, Carrie S., Finks, Shannon W.

“…Cilostazol is a unique antiplatelet agent that has been commercially available for over two decades. As a phosphodiesterase III inhibitor, it reversibly…”
Get full text

An updated comprehensive meta-analysis of bivalirudin vs heparin use in primary percutaneous coronary intervention by Shah, Rahman, MD, FACC, Rogers, Kelly C., PharmD, Matin, Khalid, MD, Askari, Raza, MD, Rao, Sunil V., MD, FACC, FSCAI

“…Background Despite several randomized controlled trials and meta-analyses, the ideal anticoagulant for patients undergoing primary percutaneous coronary…”
Get full text

Idarucizumab (Praxbind®): The first reversal agent for a direct oral anticoagulant by Finks, Shannon W., Pharm.D., FCCP, BCPS (AQ Cardiology), ASH-CHC, Professor, Rogers, Kelly C., Pharm.D, FCCP, Professor

“…Abstract Idarucizumab is a humanized monoclonal antibody fragment engineered to specifically neutralize the effects of the oral direct thrombin inhibitor…”
Get full text

A New Option for Reversing the Anticoagulant Effect of Factor Xa Inhibitors: Andexanet Alfa (ANDEXXA) by Rogers, Kelly C., Finks, Shannon W.

“…The use of direct oral anticoagulants over traditional warfarin has increased in the United States over the past 10 years because of advantages such as ease of…”
Get full text

A Practical Guide to Understanding and Treating Peripheral Artery Disease by Chilbert, Maya R, Woodruff, Ashley E, Rogers, Kelly C

“…Peripheral arterial disease (PAD) is the third leading cause of atherosclerotic morbidity after coronary heart disease and stroke yet is widely underdiagnosed…”
Get full text

Long-Term Retention of Advanced Cardiovascular Life Support Knowledge and Confidence in Doctor of Pharmacy Students by Smith, Susan E, Sikora, Andrea N, Fulford, Michael, Rogers, Kelly C

“…This study aimed to evaluate the impact of American Heart Association (AHA) advanced cardiovascular life support (ACLS) education and training on long-term…”
Get full text

Inpatient Initiation of Sacubitril/Valsartan by Chilbert, Maya R., Rogers, Kelly C., Ciriello, Domenique N., Rovelli, Richard, Woodruff, Ashley E.

“…Objective: Discuss the literature and describe strategies to overcome barriers of inpatient initiation of sacubitril/valsartan in patients with heart failure…”
Get full text

Effect of post‐primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta‐analysis of randomized controlled trials by Shah, Rahman, Matin, Khalid, Rogers, Kelly C., Rao, Sunil V.

“…Objective To compare the efficacies of various post‐percutaneous coronary intervenetion (PCI) bivalirudin doses on net adverse clinical events (NACEs) and…”
Get full text

Dual antiplatelet treatment after stenting by Shah, Rahman, Slomka, Teresa, Rogers, Kelly C

“…In most cases, based on present guidelines, physicians discontinue dual antiplatelet treatment (DAPT) 12 months after implantation of a drug-eluting stent; the…”
Get full text

The Fall Risk with Alpha blockers Given InitiaL dose or Elderly status (FRAGILE) Study by McDonnell, Chelsea C., Rogers, Kelly C., Regen, Sloan M., Finks, Shannon W.

“…Background: α-1 adrenergic antagonists are commonly prescribed, but there is question regarding their safety in patients at increased fall risk. Objective: The…”
Get full text

Effect of Post-Primary Percutaneous Coronary Intervention Bivalirudin Infusion on Acute Stent Thrombosis: Meta-Analysis of Randomized Controlled Trials by Shah, Rahman, Rogers, Kelly C, Ahmed, Agha J, King, Bryan J, Rao, Sunil V

“…The aim of this study was to evaluate the efficacy of various doses of post-primary percutaneous coronary intervention (PCI) bivalirudin infusion to prevent…”
Get full text

An Underappreciated and Prolonged Drug Interaction Leads to Ineffective Anticoagulation by Rogers, Kelly C, Neu, Daniel W, Jaeger, Melanie C, Shah, Rahman, Finks, Shannon W

“…ABSTRACTA poorly understood significant drug–drug interaction compounded by ineffective communication among providers at times of care transition most likely…”
Get full text

Activities of Memphis-area hospitals to meet National Patient Safety Goals for warfarin therapy by Finks, Shannon W, Oliphant, Carrie S, Manguso, Amy H, Rogers, Kelly C, Bridges, Gail, Haidar, Cyrine-Eliana, Lee, Kelley R, Lee, Marilyn, Lobo, Bob, May, Amanda M, Reaves, Anne, Swanson, Joseph M, Swims, Melanie, Vinson, Jason, Yates, Mary E D

“…The activities of Memphis hospitals to meet National Patient Safety Goals (NPSGs) for warfarin therapy are described. In March 2008, leadership from the…”
Get full text

Reversal Agents for Direct Oral Anticoagulants: Understanding New and Upcoming Options by Rogers, Kelly C, Shelton, Melanie P, Finks, Shannon W

“…Direct oral anticoagulants (DOACs), originally developed as an alternative for vitamin K antagonists, are shifting the landscape of antithrombotic therapy…”
Get full text

Nitrate allergy and desensitization in a patient with refractory angina by Kessler, Sarah G., Gillion, Amanda R., Pattanaik, Debendra, Rogers, Kelly C.

“…Approximately 3.4 million adults with coronary artery disease (CAD) experience angina each year.1 Most patients can be adequately treated with a combination of…”
Get full text

Use of Cilostazol in Percutaneous Coronary Interventions by Rogers, Kelly C, Faircloth, Jenna M, Finks, Shannon W

“…OBJECTIVE: To evaluate the addition of cilostazol to standard dual antiplatelet therapy (DAT) with aspirin and clopidogrel in patients receiving coronary…”
Get full text

Effect of Post–Primary Percutaneous Coronary Intervention Bivalirudin Infusion on Acute Stent Thrombosis by Shah, Rahman, MD, Rogers, Kelly C., PharmD, Ahmed, Agha J., MD, King, Bryan J., MD, Rao, Sunil V., MD

“…Abstract Objectives The aim of this study was to evaluate the efficacy of various doses of post–primary percutaneous coronary intervention (PCI) bivalirudin…”
Get full text

Key Articles of Dietary Interventions that Influence Cardiovascular Mortality by Finks, Shannon W., Airee, Anita, Chow, Sheryl L., Macaulay, Tracy E., Moranville, Michael P., Rogers, Kelly C., Trujillo, Toby C.

“…Lifestyle modifications, particularly diet, are a key component to the reduction of cardiovascular events. Diets high in carbohydrates and saturated fat have…”
Get full text

Bivalirudin for Patients with Heparin-Induced Thrombocytopenia Undergoing Cardiovascular Surgery by Czosnowski, Quinn A, Finks, Shannon W, Rogers, Kelly C

“…Objective To evaluate the uso of bivalirudin in patients with heparin-induced thrombocytopenia (HIT) undergoing cardiovascular surgery. Data Sources: Relevant…”
Get full text

Annual Influenza Vaccination: Offering Protection Beyond Infection by ROGERS, Kelly C, WALLACE, Juliet P, FOSTER, Stephan L, FINKS, Shannon W

“…Cardiovascular disease (CVD), the leading cause of death in the world, is largely preventable. An increasing amount of evidence suggests that annual…”
Get full text